de State Street Celldex Therapeutics CLDX Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 145 M | Comprar |
3,900,427
+1,096,259
| +39% | +USD 35.4 M | ﹤0.01% | 1269 |
|
|
2026
Q1 | USD 88.9 M | Vender |
2,804,168
-593,545
| -17% | -USD 16.2 M | ﹤0.01% | 1436 |
|
|
2025
Q4 | USD 92.3 M | Comprar |
3,397,713
+555,579
| +20% | +USD 14.6 M | ﹤0.01% | 1404 |
|
|
2025
Q3 | USD 73.5 M | Comprar |
2,842,134
+436,639
| +18% | +USD 10.1 M | ﹤0.01% | 1532 |
|
|
2025
Q2 | USD 49 M | Vender |
2,405,495
-400,864
| -14% | -USD 7.8 M | ﹤0.01% | 1695 |
|
|
2025
Q1 | USD 50.9 M | Vender |
2,806,359
-428,602
| -13% | -USD 9.6 M | ﹤0.01% | 1621 |
|
|
2024
Q4 | USD 81.7 M | Comprar |
3,234,961
+749,805
| +30% | +USD 20.4 M | ﹤0.01% | 1460 |
|
|
2024
Q3 | USD 84.5 M | Vender |
2,485,156
-173,932
| -7% | -USD 6.63 M | ﹤0.01% | 1422 |
|
|
2024
Q2 | USD 98.4 M | Vender |
2,659,088
-320,663
| -11% | -USD 12.1 M | ﹤0.01% | 1271 |
|
|
2024
Q1 | USD 125 M | Comprar |
2,979,751
+602,425
| +25% | +USD 24.7 M | 0.01% | 1167 |
|
|
2023
Q4 | USD 94.3 M | Comprar |
2,377,326
+84,475
| +4% | +USD 2.48 M | ﹤0.01% | 1331 |
|
|
2023
Q3 | USD 63.1 M | Vender |
2,292,851
-434,455
| -16% | -USD 13.6 M | ﹤0.01% | 1477 |
|
|
2023
Q2 | USD 92.5 M | Comprar |
2,727,306
+424,781
| +18% | +USD 14.3 M | ﹤0.01% | 1273 |
|
|
2023
Q1 | USD 82.8 M | Comprar |
2,302,525
+11,071
| +0.5% | +USD 478 k | ﹤0.01% | 1312 |
|
|
2022
Q4 | USD 102 M | Vender |
2,291,454
-880,124
| -28% | -USD 31.4 M | 0.01% | 1147 |
|
|
2022
Q3 | USD 89.2 M | Vender |
3,171,578
-57,274
| -2% | -USD 1.76 M | 0.01% | 1179 |
|
|
2022
Q2 | USD 87 M | Comprar |
3,228,852
+546,124
| +20% | +USD 15.9 M | 0.01% | 1266 |
|
|
2022
Q1 | USD 91.4 M | Comprar |
2,682,728
+314,688
| +13% | +USD 10.1 M | ﹤0.01% | 1354 |
|
|
2021
Q4 | USD 91.5 M | Comprar |
2,368,040
+510,922
| +28% | +USD 22.3 M | ﹤0.01% | 1366 |
|
|
2021
Q3 | USD 100 M | Vender |
1,857,118
-237,100
| -11% | -USD 11.1 M | 0.01% | 1258 |
|
|
2021
Q2 | USD 70 M | Comprar |
2,094,218
+217,241
| +12% | +USD 5.96 M | ﹤0.01% | 1593 |
|
|
2021
Q1 | USD 38.7 M | Comprar |
1,876,977
+66,717
| +4% | +USD 1.53 M | ﹤0.01% | 1931 |
|
|
2020
Q4 | USD 31.7 M | Comprar |
1,810,260
+1,784,873
| +7,031% | +USD 32.1 M | ﹤0.01% | 1943 |
|
|
2020
Q3 | USD 376 k | Comprar |
+25,387
| Nuevas | +USD 297 k | ﹤0.01% | 3605 |
|
|
2019
Q1 | – | Vender |
-8,976
| Cerradas | -USD 27 k | – | 3746 |
|
|
2018
Q4 | USD 27 k | Vender |
8,976
-2,041
| -19% | -USD 10 k | ﹤0.01% | 3705 |
|
|
2018
Q3 | USD 76 k | Vender |
11,017
-228
| -2% | -USD 1.6 k | ﹤0.01% | 3670 |
|
|
2018
Q2 | USD 85 k | Vender |
11,245
-140,847
| -93% | -USD 1.88 M | ﹤0.01% | 3645 |
|
|
2018
Q1 | USD 5.31 M | Comprar |
152,092
+6,278
| +4% | +USD 243 k | ﹤0.01% | 2766 |
|
|
2017
Q4 | USD 6.21 M | Comprar |
145,814
+17,459
| +14% | +USD 748 k | ﹤0.01% | 2687 |
|
|
2017
Q3 | USD 5.5 M | Vender |
128,355
-5
| -0% | -USD 187 | ﹤0.01% | 2761 |
|
|
2017
Q2 | USD 4.76 M | Vender |
128,360
-173,310
| -57% | -USD 7.67 M | ﹤0.01% | 2753 |
|
|
2017
Q1 | USD 16.3 M | Comprar |
301,670
+13,492
| +5% | +USD 703 k | ﹤0.01% | 2090 |
|
|
2016
Q4 | USD 15.3 M | Vender |
288,178
-28,341
| -9% | -USD 1.61 M | ﹤0.01% | 2088 |
|
|
2016
Q3 | USD 19.2 M | Vender |
316,519
-14,979
| -5% | -USD 933 k | ﹤0.01% | 1796 |
|
|
2016
Q2 | USD 21.8 M | Vender |
331,498
-239,250
| -42% | -USD 15.2 M | ﹤0.01% | 1691 |
|
|
2016
Q1 | USD 32.4 M | Comprar |
570,748
+350,273
| +159% | +USD 39.4 M | ﹤0.01% | 1398 |
|
|
2015
Q4 | USD 51.9 M | Comprar |
220,475
+7,739
| +4% | +USD 1.69 M | 0.01% | 1167 |
|
|
2015
Q3 | USD 33.6 M | Comprar |
212,736
+39,839
| +23% | +USD 11.3 M | ﹤0.01% | 1396 |
|
|
2015
Q2 | USD 65.4 M | Comprar |
172,897
+18,814
| +12% | +USD 7.47 M | 0.01% | 1103 |
|
|
2015
Q1 | USD 64.4 M | Vender |
154,083
-8,400
| -5% | -USD 3 M | 0.01% | 1096 |
|
|
2014
Q4 | USD 44.5 M | Vender |
162,483
-7,689
| -5% | -USD 1.91 M | ﹤0.01% | 1286 |
|
|
2014
Q3 | USD 33.1 M | Comprar |
170,172
+12,507
| +8% | +USD 2.73 M | ﹤0.01% | 1393 |
|
|
2014
Q2 | USD 38.6 M | Comprar |
157,665
+800
| +0.5% | +USD 181 k | ﹤0.01% | 1364 |
|
|
2014
Q1 | USD 41.6 M | Comprar |
156,865
+11,467
| +8% | +USD 4.39 M | ﹤0.01% | 1304 |
|
|
2013
Q4 | USD 52.8 M | Vender |
145,398
-7,532
| -5% | -USD 2.9 M | 0.01% | 1164 |
|
|
2013
Q3 | USD 81.3 M | Vender |
152,930
-17,127
| -10% | -USD 5.87 M | 0.01% | 897 |
|
|
2013
Q2 | USD 39.8 M | Comprar |
+170,057
| Nuevas | +USD 33.5 M | 0.01% | 1248 |
|
Otros fondos que tienen CLDX en su cartera
KCM
Posición de State Street en CLDX: resumen de T2 2026
State Street aumentó su participación en Celldex Therapeutics (CLDX) en 39% durante T2 2026, al comprar aproximadamente USD 35.4 M y elevar la posición a 3,900,427 acciones con un valor de USD 145 M. La posición representa ﹤0.01% de la cartera y ocupa el puesto #1269.
State Street reportó por primera vez una posición en CLDX en T2 2013 y la ha mantenido durante 47 trimestres desde entonces. Al cierre de T2 2026, 253 fondos que sigue Wall St. Rank mantienen una posición en CLDX.
- Al cierre de T2 2026, State Street tenía 3,900,427 acciones de Celldex Therapeutics con un valor de USD 145 M.
- State Street compró 1,096,259 acciones de Celldex Therapeutics en T2 2026, por un monto estimado de USD 35.4 M.
- Celldex Therapeutics representó ﹤0.01% de la cartera de State Street en T2 2026 y fue su posición número 1269.
- State Street reportó por primera vez una posición en Celldex Therapeutics en T2 2013 y la ha mantenido durante 47 trimestres desde entonces.
- Al cierre de T2 2026, 253 fondos que sigue Wall St. Rank tenían Celldex Therapeutics en cartera.
Según el Informe 13F de State Street correspondiente a T2 2026, presentado el 7 ago 2026.